Trial Details

Not Recruiting
Basic Information
Clinical ID c3378
Identifier EUCTR2004-002507-32-GB
Trial Title Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with Inflammatory bowel disease (IBD) and growth failure. - rhGH in IBD
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions Growth retardation secondary to inflammatory bowel disease in children
Interventions Trade Name: Norditropin SimpleXx 5mg/1.5ml Product Name: Norditropin SimpleXx Pharmaceutical Form: Solution for injection INN or Proposed INN: Somatropin Other descriptive name: Growth Hormone Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 5mg/1.5ml-
Participant Information
Sponsor Royal Hospital For Sick Children, Yorkhill Division
City -
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2011-02-28